IPO issuance is back—but float and liquidity will decide whether the reopening holds

The U.S. equity issuance window has reopened, but the central market-structure question is no longer simply whether companies can list. It is whether public float, securities lending, lockups, and trading venues can absorb new supply without turning price discovery into a volatility event.

The issuance window is open again

EquiLend reports that U.S. IPOs and share sales exceeded $251 billion in the first half of 2026, the highest first-half total since the 2021 issuance boom, across more than 200 announced listings. It also describes 203 announced listings and Nasdaq’s strongest first half in exchange history.^[1]

That headline is important, but proceeds alone are an incomplete measure of market health. A large deal can create liquidity in the aggregate while leaving a relatively small freely tradable float at launch. The result can be a familiar sequence: scarce shares, sharp opening moves, rising borrow demand, and then a second price-discovery phase as more inventory becomes available.

The current calendar shows that the reopening is broad rather than confined to one type of issuer. Recent U.S. activity has included biotech offerings, a defense-technology IPO from Lyntris, and SPAC issuance. Longbridge reported three IPOs and one SPAC pricing during an August week, while IPOScoop described a cluster of biotech deals that raised more than $1 billion in one week.^[2]

Float is the transmission mechanism

An IPO changes the supply of tradable shares in stages. The initial offering establishes a reference price, but lockups determine when employees, founders, and early investors can add inventory. Secondary offerings and registered share sales can accelerate that process; buybacks can work in the opposite direction by reducing shares outstanding or offsetting some issuance.

SpaceX is a useful live case study—not because one company determines the market, but because its scale makes the mechanics unusually visible. CNN reported that more than 900 million shares became eligible to trade on Aug. 6, more than doubling the publicly available shares and lifting the estimated tradable share count to about 12% of total shares. The stock rose more than 6% that day, demonstrating that an unlock is a change in optional supply, not a guaranteed wave of selling.^[3]

The same report noted that additional unlocks are scheduled and that the Nasdaq 100’s quarterly rebalance could reflect the higher share availability. That creates two distinct channels to monitor: direct selling by newly eligible holders and potential index-weight changes as the float-adjusted market capitalization evolves. Neither outcome is mechanical; both depend on price, holder behavior, and index rules.^[3]

A practical supply checklist

The borrow market often sees the stress first

EquiLend’s H1 review says global securities-lending revenue reached $9.1 billion, up 34% year over year, while loan balances reached $4.38 trillion. Its examples show why an IPO can matter to market plumbing even when the stock’s headline performance looks ordinary.^[1]

Cerebras reportedly moved from 1.55 million shares on loan shortly after listing to 5.3 million within a week, with utilization and fees later remaining elevated as short demand grew. Quantinuum, by contrast, had a muted debut but immediately exhibited very high borrow fees because available inventory was constrained. SpaceX showed a third pattern: large loan balances and rapidly growing short activity as supply and demand developed at much greater scale. These are reported securities-finance observations, not claims about the future direction of any stock.^[1]

The broader lesson is that liquidity has several dimensions. A stock can trade actively while still being expensive to borrow, difficult to source, or vulnerable to gaps when marginal buyers and sellers disagree. Volume is visible; inventory, utilization, settlement capacity, and concentration are less visible but often more revealing.

The rulebook is also moving

The SEC proposed registered-offering reforms in May that would expand access to shelf offerings, broaden certain offering and research-report flexibilities, simplify incorporation by reference for Form S-1, and preempt state registration and qualification requirements for registered offerings. The proposal also would extend disclosure accommodations to an estimated 81% of current public companies and provide new companies at least five years of those accommodations, subject to the proposal’s conditions and the rulemaking process.^[4]

If adopted, those changes could lower friction for follow-on capital raising and make it easier for smaller and midsize companies to remain public. The trade-off to watch is straightforward: easier access to issuance can improve financing resilience, but it can also increase the frequency with which investors must evaluate dilution, float growth, and the use of proceeds.

Market venues are adapting as well. Nasdaq announced an agreement to acquire LeveL Markets, an off-exchange equity execution venue whose platform reaches more than 2,500 buy-side and sell-side clients. Nasdaq said LeveL ranked as the third-largest U.S. alternative trading system by volume, executed across more than 7,000 symbols daily, and processed hundreds of millions of shares daily; those figures are company-provided and remain subject to the transaction’s closing and integration risks.^[5]

The development illustrates the direction of travel: liquidity is increasingly distributed across exchanges, ATSs, and other execution venues. That can improve access and specialization, but it also makes transparency, resilience, routing, and the measurement of consolidated liquidity more important.

What the current evidence does—and does not—say

The evidence supports three conclusions:

1. Issuance has materially recovered. H1 proceeds and listing counts indicate a much more open primary market than the post-2021 lull.^[1]
2. Supply arrives unevenly. Lockups and staged releases can matter as much as the initial deal, and SpaceX’s first major unlock produced a positive session rather than the presumed selloff.^[3]
3. Liquidity is not one number. Borrow costs, utilization, float, venue mix, and index treatment can diverge from headline trading volume.^[1][5]

What the evidence does not establish is a universal effect of IPOs or lockup expirations on prices. A newly available share is an option to sell, not an instruction to sell. A larger float may reduce scarcity, but it may also broaden ownership and improve trading conditions. The base rate is therefore conditional: the market response depends on demand, the quality of the business narrative, the amount and timing of new supply, and how efficiently that supply can be intermediated.

What to watch next

• The H2 IPO and secondary pipeline: Track announced deals separately from priced offerings, and primary proceeds separately from insider or shareholder sales.
• Lockup calendars: Record the number of shares becoming eligible, not just the headline expiry date; distinguish eligibility from actual selling.
• Borrow conditions: Watch utilization, fees, and shares on loan around new listings and unlocks for signs of constrained inventory or crowded positioning.
• Float-adjusted index treatment: Changes in publicly available shares can affect index weights and passive flows, as the SpaceX example highlights.^[3]
• SEC offering reform: The May proposals remain proposals; monitor the comment process and any final rule text before treating the potential changes as operative.^[4]
• Venue consolidation and ATS growth: Nasdaq’s LeveL transaction is one marker for a market increasingly organized around multiple liquidity pools. Watch execution quality, transparency, and operational resilience alongside volume.^[5]

The reopening of the IPO market is a capital-formation story. The next phase is a distribution story: who can trade, when they can trade, where liquidity sits, and how much volatility the system absorbs as private-market supply becomes public.